• June 3-6, 2024
  • San Diego Convention Center, California



Varda Space Industries, Inc.

Monday, June 03, 2024
Platform for Therapeutics
Company Presentation Theater 4
Founded in 2020, Varda Space Industries is a private, venture-backed organization developing a revolutionary microgravity platform for the development, formulation, and production of small molecule and biologic therapeutics. Varda’s microgravity platform is grounded in decades of proven research conducted on NASA’s space stations. By eliminating factors such as natural convection and sedimentation, processing in a microgravity environment provides a unique path to formulating small molecules and biologics that traditional manufacturing processes cannot address. As an example, a recent Keytruda study by Merck validated the ability of microgravity to improve the particle size distribution and offer a path toward an IV to subcutaneous reformulation. As a result, Merck recently announced the release of an easier-to-use, more patient compliant subcutaneous formulation of Keytruda. The new subcutaneous formulation will extend the critical patent life through 2040.
Varda Space Industries, Inc.
Company Website: http://www.varda.com
Lead Product in Development: Undisclosed
Number Of Unlicensed Products (For Which You Are Seeking Partners): Strategic partnering and platform licensing opportunities available

Company HQ City

El Segundo

Company HQ State


Company HQ Country

United States

CEO/Top Company Official

William Bruey

Development Phase of Primary Product

Primary Speaker
Mark Herbert, MSc
Vice President, Business Development
Varda Space Industries, Inc.
Back to Session List


Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.